INS and type 2 diabetes mellitus: In humans, Jansen et al. [9] found a significant reduction in plasma zinc levels in type 1 diabetes and T2DM patients compared to healthy controls and suggest that oral supplementation of zinc may qualify as a potential adjunct therapy in T2DM patients by promoting insulin signaling.